Our Media - Meet our experts: Regulatory aspects

Pharmacometrics and quantitative clinical pharmacology are now almost routinely integrated in the process of drug development in many pharmaceutical companies. Nevertheless, this research area is continuously evolving and shows increasingly high impact in supporting both in-house and regulatory decision-making. Meet Céline Sarr and Jakob Ribbing, sharing their experiences about implementing pharmacometrics in a variety of projects across many different therapeutic areas and organisations.